11 results
·
29ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
AART PECTORALIS IMPLANT
FDA 510(k)
FDA Class 2
·Ear, Nose, Throat
NA
FDA UDI
STERILMED, INC.·10888551021333·BUR CARBIDE CYLINDRICAL 2 FLUTES
ULTRAPOWER
FDA UDI
Conmed Corporation·10845854000809·ULTRAPOWER BUR, ROUND/CYLINDRICAL (LIME), 3 MM
T:SLIM G5 SYSTEM
FDA Adverse Event
Malfunction
·TANDEM DIABETES CARE·Product code OYC·March 27, 2018
DANIELS SHARPSMART REUSABLE SHARPS CONTAINER
FDA 510(k)
FDA Class 2
·General Hospital
ULTEGRA SYSTEM RAPID PLATELET FUNCTION ASSAY (RPFA)
FDA 510(k)
FDA Class 2
·Hematology
ADVIA CENTAUR XP HBC TOTAL (HBCT) ASSAY
FDA Adverse Event
Malfunction
·SIEMENS HEALTHCARE DIAGNOSTICS, INC.·Product code LOM·March 26, 2013
CL MICRO EXT SET W/CL INJ SITE60IN 1.5M LL 0.5ML STERILE NON
FDA Adverse Event
Malfunction
·BAXTER HEALTHCARE - AIBONITO·Product code FPA·March 17, 2011
NEUROTHERM DISPOSABLE RADIOFREQUENCY CANNULA
FDA Adverse Event
Malfunction
·NEUROTHERM, INC.·Product code GXI·July 8, 2014
Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone
FDA Enforcement
Class II
·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012
The Propaq LT Series monitors. Model numbers 802LTAN, 802LT0N, and 802LTRN. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medical-surgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. intended to be used by clinicians and medically qualified personnel for single or multiparameter vital signs monitoring of ambulatory and nonambulatory patients, including neonate, pediatric and adult patients. These devices are indicated for ECG, noninvasive blood pressure (NIBP), respiration and SpO2. The most likely locations for patients to be monitored by these devices are hospital general medicalsurgical, telemetry, and intermediate care floors, hospital emergency departments, transport, emergency medical services, and other healthcare applications. The monitors can be used as stand-alone devices or as devices networked to an Acuity Central Station through wireless communication over a Welch Allyn FlexNet network.
FDA Enforcement
Class II
·Terminated·Welch Allyn Protocol, Inc·January 15, 2014